Producer
Sichuan Hebang Biotechnology Co., Ltd.
Chinese domestic DL-methionine producer (Sichuan province); completed a new 70,000 tonnes/year production line in 2025, raising domestic market share ~9% and representing the fastest-growing challenger to the ABCD Western players; part of China's strategic push to reduce amino acid import dependency; listed on Shenzhen Stock Exchange
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Sichuan Hebang Biotechnology Co., Ltd. supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Sichuan Hebang Biotechnology Co., Ltd. makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
DL-Methionine Production
75%Other Amino Acids & Agricultural Chemicals
25%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Note2025
Chinese domestic methionine producers including Sichuan Hebang have been rapidly expanding capacity with state support, mirroring China's playbook in lysine, threonine, and other feed amino acids. Hebang's 70,000 MT/year line came online in 2025. If this trajectory continues, China's domestic producers could approach 40-50% of global methionine capacity by 2030 — potentially transforming the market from a Western-dominated oligopoly to a Chinese-majority supply base, similar to what happened in vitamin production.
Intel Market Research ↗Origin2023
Sichuan Hebang Biotechnology represents China's deliberate strategy to build domestic methionine production capacity to reduce dependence on Western companies (Evonik's Degussa acquisition, Adisseo, Novus/Mitsui). DL-methionine is the one essential amino acid that cannot be synthesized by most monogastric animals and must be supplemented in chicken and pig feed -- it's indispensable for modern industrial poultry and swine production. For decades, the global methionine market was dominated by German (Evonik/Degussa), French (Adisseo), and Japanese-US (Novus/Mitsui) companies. China, as the world's largest pork and chicken producer, recognized this dependence as a strategic vulnerability. Hebang and other Chinese companies began building methionine production with government support in the 2010s. Hebang's 70,000 MT/yr capacity expansion in 2025 is explicitly part of China's 'import substitution' strategy for feed amino acids, modeled on its success in polysilicon and solar cells.
Sichuan Hebang Biotechnology Co. Ltd. ↗